These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22837094

  • 1. Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.
    Moustafa M, Aronoff GR, Chandran C, Hartzel JS, Smugar SS, Galphin CM, Mailloux LU, Brown E, Dinubile MJ, Kartsonis NA, Guris D.
    Clin Vaccine Immunol; 2012 Sep; 19(9):1509-16. PubMed ID: 22837094
    [Abstract] [Full Text] [Related]

  • 2. The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.
    Harro CD, Betts RF, Hartzel JS, Onorato MT, Lipka J, Smugar SS, Kartsonis NA.
    Vaccine; 2012 Feb 21; 30(9):1729-36. PubMed ID: 22192849
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans.
    Zorman JK, Esser M, Raedler M, Kreiswirth BN, Ala'Aldeen DA, Kartsonis N, Smugar SS, Anderson AS, McNeely T, Arduino JM.
    Hum Vaccin Immunother; 2013 Sep 21; 9(9):1857-64. PubMed ID: 23778314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.
    Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.
    Vaccine; 2004 Dec 16; 23(5):656-63. PubMed ID: 15542186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia.
    Chen Z, Gou Q, Xiong Q, Duan L, Yuan Y, Zhu J, Zou J, Chen L, Jing H, Zhang X, Luo P, Zeng H, Zou Q, Zhao Z, Zhang J.
    Front Immunol; 2021 Dec 16; 12():684823. PubMed ID: 34122448
    [Abstract] [Full Text] [Related]

  • 16. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Creech CB, Frenck RW, Sheldon EA, Seiden DJ, Kankam MK, Zito ET, Girgenti D, Severs JM, Immermann FW, McNeil LK, Cooper D, Jansen KU, Gruber W, Eiden J, Anderson AS, Baber J.
    Vaccine; 2017 Jan 05; 35(2):385-394. PubMed ID: 27866765
    [Abstract] [Full Text] [Related]

  • 17. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE, Hennessey JP.
    Vaccine; 2012 Dec 14; 30(52):7594-600. PubMed ID: 23099329
    [Abstract] [Full Text] [Related]

  • 18. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S, Mohabati Mobarez A, Imani Fooladi AA, Amani J, Emaneini M.
    Med Microbiol Immunol; 2016 Feb 14; 205(1):47-55. PubMed ID: 26155981
    [Abstract] [Full Text] [Related]

  • 19. S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.
    Marshall HS, Baber J, Richmond P, Nissen M, Shakib S, Kreiswirth BN, Zito ET, Severs J, Eiden J, Gruber W, Jansen KU, Jones CH, Anderson AS.
    J Infect; 2019 Dec 14; 79(6):582-592. PubMed ID: 31585191
    [Abstract] [Full Text] [Related]

  • 20. Immunity to Staphylococcus aureus: Implications for Vaccine Development.
    Proctor RA.
    Microbiol Spectr; 2019 Jul 14; 7(4):. PubMed ID: 31298209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.